ATS is always one of our favorite weeks of the year, and we’d love to use our time in Dallas to connect with you. As you start thinking about your schedule for the week, here are five good reasons to connect with the Propeller team about integrating digital medicines into your clinical practice.
1. Demo our digital medicine platform.
If you’ve never used Propeller to manage your patients’ asthma or COPD, we’d like the chance to show you our platform. Propeller connects to your patients’ existing inhalers and communicates data on their medication use directly to their computer or smartphone and your provider dashboard.
Propeller helps you manage your patients’ respiratory disease by delivering:
- Data on your patients’ rescue usage history and location, adherence statistics, control status, symptoms and trigger trends
- Email notifications if a patient transitions to poorly-controlled asthma status or is at risk for an exacerbation
- Simple, one-page summary reports with data on a patient’s past 30 days of rescue use, adherence, control status and trends
Stop by Booth #3522 to demo our platform or email provider@propellerhealth.com to schedule time with our team.
2. Pick up a clinician demo kit.
ATS can be a bit of a blur. To make sure you can take away the most useful information for your practice, we’ve put together a clinician demo kit that includes a demo sensor, a comprehensive handbook about Propeller for clinicians, and a guide to experiencing the Propeller app from the patient perspective.
We’ll have demo kits on hand at Booth #3522, or email provider@propellerhealth.com to have one delivered directly to your office back home.
3. Talk with Propeller leadership about our vision to help you improve respiratory care.
We believe that traditional, analog medicines will soon be a thing of the past. With platforms like Propeller’s, clinicians will have the ability not only to prescribe medicines to patients, but also to know that those medicines are being taken and how well they’re working. This will result in:
- Higher levels of patient adherence (patients on the Propeller program showed an average adherence of 57%, compared to 36% in the control group)
- Higher levels of asthma control in your patient population (over 60% of patients with uncontrolled asthma achieved controlled status within one year of starting on Propeller)
- Stronger relationships between physicians and patients, built on a foundation of objective data
Our commercial, research and clinical teams will be at ATS to talk with you about the next five to 10 years in digital respiratory management. We’d love to see you and hear your thoughts.
4. Share your ideas for integrating Propeller into your clinical practice.
You’re an expert on the realities of managing respiratory disease day-to-day. We want to hear from you about what it would take to implement a digital health platform in your practice — and the roadblocks that might get in your way. Stop by Booth #3522 to discuss, or you can always email us at provider@propellerhealth.com.
5. Hear about our new research on asthma and COPD.
Propeller is presenting four pieces of research on asthma and COPD at ATS, in addition to five more pieces of research that use Propeller’s platform from our partners at GSK, Children’s Hospital Colorado and Cleveland Clinic. See our research presented on the schedule below:
Monday, May 20
- Monitoring Daily Maintenance Medication Adherence in Patients with COPD
Ben Theye, Rahul Gondalia, David A. Stempel, Propeller Health
Monday May 20, 2019 9:15 AM – 4:15 PM
Area D (Hall F, Level 2), KBHCCD
Tuesday, May 21
- Prediction of COPD Exacerbations with Electronic Inhaler Monitoring
Khaled Alshabani, Michael Smith, Amy Attaway, Richard Rice
Tuesday May 21, 2019 2:15 PM – 4:15 PM
Room C141/C143/C149 (Level 1), KBHCCD
Wednesday, May 22
- The Association of Digitally Collected Short-Acting Beta-Agonist and Maintenance Medication Use and COPD Assessment Test
Rahul Gondalia, Ben Theye, David A. Stempel, Propeller Health
Wednesday, May 22, 2019, 9:15 AM – 11:15 AM
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown - Digitally Recorded Controller and Rescue Medication Use Vary by Age in Patients with Asthma
Heather E. Hoch, William C. Anderson III, Rahul Gondalia, Leanne Kaye, Stanley J. Szefler, David A. Stempel, Propeller and the University of Colorado School of Medicine
Wednesday May 22, 2019 9:15 AM – 11:15 AM
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown - Real-life Patterns of Short-Acting Beta-Agonist Use in Patients with COPD Vary by Time of Day and Season
William C. Anderson III, Heather E. Hoch, Rahul Gondalia, Leanne Kaye, Stanley J. Szefler, David A. Stempel, Propeller and the University of Colorado School of Medicine
Wednesday May 22, 2019 9:15 AM – 11:15 AM
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown - Adherence and asthma control in patients using FF/VI with and without using a sensor that monitors adherence
Richard H. Stanford, Carlyne Averell, Phaedra T. Johnson, Erin K. Buysman, Maureen Carlyle, GlaxoSmithKline
Wednesday May 22, 2019 9:15 AM – 11:15 AM
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown - Controller adherence and albuterol use among adult patients with asthma on once or twice-daily ICS/LABA therapy using sensor technology to assess outcomes
Richard H. Stanford, Carlyne M. Averell, Phaedra T. Johnson, Erin K. Buysman, Maureen H. Carlyle, GlaxoSmithKline
Wednesday May 22, 2019 9:15 AM – 11:15 AM
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown - Evaluating adherence data in the clinical setting-what tools should we use to describe behavior?
Heather E. Hoch, K. Pickett, J. Brinton, Stanley J. Szefler
Wednesday May 22, 2019 11:15 AM – 1:00 PM
Area H (Hall F, Level 2), KBHCCD - Breathing Counts: Addressing Barriers To Medication Use In High Risk Children With Asthma
Heather E. Hoch, M. Meier, J. Brinton, Stanley J. Szefler, University of Colorado School of Medicine
Wednesday May 22, 2019 1:30 PM – 3:30 PM
Dallas Ballroom E-F (Level 3), Omni Dallas Downtown
Thanks for working with us to improve the patient experience of respiratory disease. We’ll see you at ATS.